ENDONOVO THERAPEUTICS, INC. (ENDV) › Shareholders' EquityENDONOVO THERAPEUTICS, INC. (ENDV) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $235.4K2010: $166.1K2011: -$447.2K2012: -$1.88M2013: -$4.13M2014: -$4.69M2015: -$9.28M2016: -$8.56M2017: -$9.55M2018: -$11.39M2019: -$20.50M2020: -$14.37M2021: -$15.77M2022: -$32.18M-$32.18M2009Shareholders' Equity (USD)2022Fiscal YearShareholders' EquityChange YoY2022-$32.18M-104.0%2021-$15.77M-9.7%2020-$14.37M+29.9%2019-$20.50M-80.0%2018-$11.39M-19.3%2017-$9.55M-11.5%2016-$8.56M+7.7%2015-$9.28M-97.7%2014-$4.69M-13.6%2013-$4.13M-119.7%2012-$1.88M-320.6%2011-$447.2K-369.3%2010$166.1K-29.5%2009$235.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share